Literature DB >> 25311987

A comparison of virulence patterns and in vivo fitness between hospital- and community-acquired methicillin-resistant Staphylococcus aureus related to the USA400 clone.

M A Guimarães1, M S Ramundo, M A Américo, M C de Mattos, R R Souza, E S Ramos-Júnior, L R Coelho, A Morrot, P A Melo, S E L Fracalanzza, F A Ferreira, A M S Figueiredo.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) isolates genetically related to the CA-MRSA clone MW2/USA400 (ST1-SCCmecIV lineage) from the United States have emerged in hospitals in Rio de Janeiro and are associated with nosocomial bloodstream infections. To understand the virulence mechanisms involved in the adaptability of ST1 isolates as a hospital pathogen in Rio de Janeiro, we compared the virulence traits and fitness properties of the Brazilian isolates with those displayed by the CA-MRSA isolates from the United States. Similar to the USA400 from the United States, all the Brazilian isolates tested carried the genes encoding SEH and LukDE. In contrast, none of the Brazilian isolates carried the lukSF PVL, sea, sec, and sek genes. Competition experiments in mice demonstrated a significant increase in the fitness for the CA-MRSA isolates MW2 and USA400-0051 from the United States compared to other isolates. In the foreign body animal model, 83 % more North-American bacterial cells were recovered compared to the Brazilian ST1 isolates. Differences in gene expression of important virulence factors were detected. Transcription of rnaIII and psmα3 was increased about two-fold in the isolates from the United States, and sasG about two-fold in the Brazilian isolates. Thus, it is possible that the virulence attenuation observed among the Brazilian hospital isolates, associated with the acquisition of multiple resistant determinants, are consequences of microevolutionary events that contributed to the necessary fitness adjustment of this lineage, allowing a typically community-acquired MRSA (MW2/USA400) to emerge as a successful hospital pathogen (Brazilian ST1-SCCmecIV).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25311987     DOI: 10.1007/s10096-014-2253-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  64 in total

1.  Suppression of autolysis and cell wall turnover in heterogeneous Tn551 mutants of a methicillin-resistant Staphylococcus aureus strain.

Authors:  B L de Jonge; H de Lencastre; A Tomasz
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

2.  Clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus carrying SCCmecIV in a university hospital in Porto Alegre, Brazil.

Authors:  Letícia V Scribel; Maria C Silva-Carvalho; Raquel Rodrigues Souza; Silvana V Superti; Carlos H C Kvitko; Agnes M S Figueiredo; Alexandre P Zavascki
Journal:  Diagn Microbiol Infect Dis       Date:  2009-09-19       Impact factor: 2.803

3.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

Authors:  Yves Gillet; Bertrand Issartel; Philippe Vanhems; Jean-Christophe Fournet; Gerard Lina; Michèle Bes; François Vandenesch; Yves Piémont; Nicole Brousse; Daniel Floret; Jerome Etienne
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

4.  Comparison of in vitro and in vivo systems to study ica-independent Staphylococcus aureus biofilms.

Authors:  Fabienne Antunes Ferreira; Raquel Rodrigues Souza; Raquel Regina Bonelli; Marco Antônio Américo; Sérgio Eduardo Longo Fracalanzza; Agnes Marie Sá Figueiredo
Journal:  J Microbiol Methods       Date:  2012-01-24       Impact factor: 2.363

5.  Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury.

Authors:  Binh An Diep; Liana Chan; Pierre Tattevin; Osamu Kajikawa; Thomas R Martin; Li Basuino; Thuy T Mai; Helene Marbach; Kevin R Braughton; Adeline R Whitney; Donald J Gardner; Xuemo Fan; Ching W Tseng; George Y Liu; Cedric Badiou; Jerome Etienne; Gerard Lina; Michael A Matthay; Frank R DeLeo; Henry F Chambers
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

6.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

7.  Pathoadaptive mutations that enhance virulence: genetic organization of the cadA regions of Shigella spp.

Authors:  W A Day; R E Fernández; A T Maurelli
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

8.  The first case report of non-nosocomial healthcare-associated infective endocarditis due to methicillin-resistant Staphylococcus aureus USA400 in Rio de Janeiro, Brazil.

Authors:  P V Damasco; F S Cavalcante; R C Chamon; D C Ferreira; S S Rioja; M V Potsch; M P Pastura; V D Marques; M B Castier; E A Marques; K R N Santos
Journal:  Infection       Date:  2013-03-02       Impact factor: 3.553

9.  A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB.

Authors:  Eoghan O'Neill; Clarissa Pozzi; Patrick Houston; Hilary Humphreys; D Ashley Robinson; Anthony Loughman; Timothy J Foster; James P O'Gara
Journal:  J Bacteriol       Date:  2008-03-28       Impact factor: 3.490

10.  Biofilm formation by clinical isolates and the implications in chronic infections.

Authors:  Carlos J Sanchez; Katrin Mende; Miriam L Beckius; Kevin S Akers; Desiree R Romano; Joseph C Wenke; Clinton K Murray
Journal:  BMC Infect Dis       Date:  2013-01-29       Impact factor: 3.090

View more
  5 in total

1.  What is behind the epidemiological difference between community-acquired and health-care associated methicillin-resistant Staphylococcus aureus?

Authors:  Agnes M S Figueiredo
Journal:  Virulence       Date:  2017-06-20       Impact factor: 5.882

2.  Infectious Dose Dictates the Host Response during Staphylococcus aureus Orthopedic-Implant Biofilm Infection.

Authors:  Debbie Vidlak; Tammy Kielian
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

3.  Treatment outcome measures for randomized controlled trials of antibiotic treatment for acute bacterial skin and skin structure infections in the emergency department setting.

Authors:  Michael Quirke; Abel Wakai
Journal:  Int J Emerg Med       Date:  2015-04-22

4.  Characterization of the Three New Kayviruses and Their Lytic Activity Against Multidrug-Resistant Staphylococcus aureus.

Authors:  Natalia Łubowska; Bartłomiej Grygorcewicz; Katarzyna Kosznik-Kwaśnicka; Agata Zauszkiewicz-Pawlak; Alicja Węgrzyn; Barbara Dołęgowska; Lidia Piechowicz
Journal:  Microorganisms       Date:  2019-10-18

5.  Reductive evolution of virulence repertoire to drive the divergence between community- and hospital-associated methicillin-resistant Staphylococcus aureus of the ST1 lineage.

Authors:  Marina Farrel Côrtes; Ana Maria N Botelho; Paula Terra Bandeira; William Mouton; Cedric Badiou; Michèle Bes; Nicholas C B Lima; André Elias R Soares; Rangel C Souza; Luiz G P Almeida; Patricia Martins-Simoes; Ana T R Vasconcelos; Marisa F Nicolás; Frédéric Laurent; Paul J Planet; Agnes M S Figueiredo
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.